Welcome to the Eczema Studies Page
Interested in sharing your story about health, illness, or research? Patients and caregivers are needed to participate in a research study to help learn more about topics that are important to you and that may improve health and health care. Participation involves one 45-minute session that takes place over the phone. Eligible participants must be able to read and understand English.
Have you had atopic dermatitis (eczema) for at least 2 years? If so, you may be able to participate in a study to help determine how safe and effective a study drug, called nemolizumab, is in treating atopic dermatitis. Study participation may last up to 60 weeks and may involve up to 16 study visits. Compensation is provided.
Have you been diagnosed with moderate to severe eczema? Are you ages 18-75? If so, you may be eligible to participate in a study to help researchers evaluate an investigational drug called upadacitinib, which is being tested as a treatment for several inflammatory diseases, including eczema. Compensation provided.
Have you been diagnosed with moderate-to-severe atopic dermatitis (eczema) for at least the past 2 years? If so, you may be eligible to participate in a study of an investigational drug called risankizumab in subjects with atopic dermatitis. Involves 11 visits over up to 65 weeks. Compensation is provided.
Have you been diagnosed with eczema that is not responding to treatment? If so, you may be eligible to participate in a study to help researchers find out if an investigational drug called tradipitant is safe and effective at treating eczema. Eligible participants are 18-70 years old and have chronic itchy skin despite the use of steroids and antihistamines. Compensation provided.
You may be able to change the future of medicine. The All of Us PA Research Program is enrolling adults 18 years of age or older. This may be your chance to improve how your children and your children’s children receive medical care.
